Article info
Copy-number variation
Short report
Homozygous deletion of Tenascin-R in a patient with intellectual disability
- Correspondence to Dr Myriam Srour, Montreal Children's Hospital, McGill University, 2300 Rue Tupper, A-508 Montreal, Quebec H3H 1P3, Canada; myriam.srour{at}muhc.mcgill.ca
Citation
Homozygous deletion of Tenascin-R in a patient with intellectual disability
Publication history
- Received February 16, 2012
- Revised May 10, 2012
- Accepted May 11, 2012
- First published June 22, 2012.
Online issue publication
July 30, 2016
Article Versions
- Previous version (30 July 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement 1 - Online tables
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.